Dose-response curves were determined as for the drug screen, except that a twofold dilution series of each drug was generated and then transferred to the plates. After incubation, an MTS assay was performed and the IC50 values for the drugs were calculated.
Drug combination trials
To determine the effect of combinations of two drugs, drug concentrations ranging from 4× IC50 to 1/4× IC50 were assayed alone and in combination in a checkerboard dilution series. The combination plates were prepared with pairs of agents arranged on each 96-well plate as a duplicate 6×6 matrix. This arrangement allowed the same data set to be interpreted using the Bliss independence, Loewe additivity, and combination index (CI) approaches [47] .
Myxoid liposarcoma cells (1,000-2,000 cells per well) were incubated for 18 h at 37°C in 5% CO2. A Zephyr liquid handling robot (Perkin Elmer, Waltham, MA) was used to create drug combinations and transfer them to the plates, which were then incubated for 5 days at 37°C in 5% CO2. An MTS assay was then performed.
The data were analyzed with several mathematical models to generate dose-response curves that show changes in absorbance with increasing drug concentrations. An isobologram that displays an additive effect of a drug combination (i.e., the effect is equal to that of each single agent added together) is depicted by points along the line of additivity. A synergistic effect is one that is greater than the combined effect of each single agent, which is shown by points below the line of additivity. An antagonistic effect is less than the additive effect and is denoted by points 
